PMC:7352545 / 50024-50198 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T424","span":{"begin":3,"end":19},"obj":"Body_part"},{"id":"T425","span":{"begin":14,"end":19},"obj":"Body_part"}],"attributes":[{"id":"A424","pred":"fma_id","subj":"T424","obj":"http://purl.org/sig/ont/fma/fma66768"},{"id":"A425","pred":"fma_id","subj":"T425","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"II epithelial cells due to the ACE2–TMPRSS2 interaction. Therefore, supplementation of ACE2 (soluble ACE2) or Ang-1 to Ang-7 should be a way to reduce SARS-CoV-2-related symp"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T183","span":{"begin":151,"end":159},"obj":"Disease"}],"attributes":[{"id":"A183","pred":"mondo_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"II epithelial cells due to the ACE2–TMPRSS2 interaction. Therefore, supplementation of ACE2 (soluble ACE2) or Ang-1 to Ang-7 should be a way to reduce SARS-CoV-2-related symp"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T683","span":{"begin":3,"end":13},"obj":"http://purl.obolibrary.org/obo/CL_0000066"},{"id":"T684","span":{"begin":14,"end":19},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T685","span":{"begin":135,"end":136},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"II epithelial cells due to the ACE2–TMPRSS2 interaction. Therefore, supplementation of ACE2 (soluble ACE2) or Ang-1 to Ang-7 should be a way to reduce SARS-CoV-2-related symp"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T77723","span":{"begin":0,"end":2},"obj":"Chemical"}],"attributes":[{"id":"A57241","pred":"chebi_id","subj":"T77723","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"II epithelial cells due to the ACE2–TMPRSS2 interaction. Therefore, supplementation of ACE2 (soluble ACE2) or Ang-1 to Ang-7 should be a way to reduce SARS-CoV-2-related symp"}